Hercules Capital Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF88.87 | CHF105.00 | 21.10% | 9 | CHF181.47B |
| SAN | Sanofi | Outperform |
16
|
91.84€ | 102.80€ | 18.68% | 9 | 109.51€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.64 | $58.15 | 20.97% | 10 | $90.60B |
| MRK | Merck KGaA | Outperform |
18
|
149.95€ | 190.06€ | 22.04% | 4 | 63.48€B |
| BIIB | Biogen | Outperform |
10
|
$215.50 | $299.62 | 33.87% | 13 | $29.36B |
| BAYN | Bayer | Hold |
5
|
27.59€ | 45.15€ | 8.74% | 4 | 25.86€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr1.97k | kr2.71k | 30.20% | 14 | kr130.39B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$14.10 | $11.59 | 13.48% | 9 | $14.57B |
| ARCC | Ares Capital | Outperform |
14
|
$20.81 | $21.50 | 5.72% | 14 | $12.49B |
| FSK | FS KKR Capital | Hold |
13
|
$19.22 | $21.55 | 4.06% | 10 | $5.60B |
| ALKS | Alkermes | Outperform |
10
|
$24.88 | $33.27 | 36.66% | 3 | $4.13B |
| MAIN | Main Street Capital | Hold |
12
|
$49.71 | $44.17 | -8.47% | 6 | $3.75B |
| GBDC | Golub Capital BDC | Outperform |
14
|
$17.58 | $15.90 | -3.30% | 5 | $2.88B |
| PSEC | Prospect Capital | Underperform |
12
|
$5.24 | $5.50 | 0.19% | 0 | $2.36B |
| TSLX | Sixth Street Specialty Lending | Outperform |
14
|
$21.69 | $21.91 | 3.73% | 10 | $1.90B |
| GSBD | Goldman Sachs BDC | Hold |
12
|
$15.77 | $14.50 | -4.88% | 5 | $1.72B |
| OCSL | Oaktree Specialty Lending Corp | Outperform |
14
|
$19.87 | $7.79 | 1.91% | 6 | $1.59B |
| NMFC | New Mountain Finance | Outperform |
14
|
$12.72 | $13.14 | 2.20% | 6 | $1.29B |
| CSWC | Capital Southwest | Outperform |
15
|
$25.96 | $22.81 | 0.15% | 6 | $1.08B |
| MFIC | MidCap Financial Investment | Outperform |
13
|
$15.26 | $13.86 | -1.70% | 7 | $999.03M |
| BBDC | Barings BDC | Outperform |
16
|
$9.34 | $9.86 | 9.74% | 6 | $956.52M |
| TCPC | BlackRock TCP Capital | Hold |
14
|
$10.16 | $12.50 | 5.81% | 6 | $874.74M |
| CGBD | Carlyle Secured Lending | Hold |
14
|
$17.33 | $15.42 | -7.67% | 6 | $848.28M |
| SLRC | SLR Investment | Hold |
12
|
$15.54 | $15.50 | 2.96% | 9 | $809.59M |
| PFLT | PennantPark Floating Rate Capi... | Hold |
12
|
$11.45 | $11.60 | 0.44% | 4 | $693.93M |
| FDUS | Fidus Investment | Outperform |
14
|
$20.38 | $20.92 | 3.04% | 6 | $611.70M |
| GAIN | Gladstone Investment | Outperform |
14
|
$14.20 | $14.60 | -1.41% | 5 | $511.08M |
| PNNT | PennantPark Investment | Outperform |
13
|
$7.18 | $7.09 | -2.51% | 5 | $457.22M |
| GLAD | Gladstone Capital | Hold |
12
|
$21.63 | $10.50 | 1.71% | 4 | $447.27M |
| TPVG | TriplePoint Venture Growth BDC | Hold |
12
|
$9.49 | $10.66 | 0.11% | 8 | $392.25M |
| HRZN | Horizon Technology Finance | Hold |
12
|
$11.62 | $11.59 | -13.94% | 7 | $383.74M |
| SAR | Saratoga Investment | Outperform |
4
|
$23.66 | $27.61 | 5.66% | 4 | $322.22M |
| SCM | Stellus Capital Investment | Hold |
14
|
$14.00 | $14.08 | -1.79% | 5 | $307.60M |
| BKCC | BlackRock Capital Investment | - |
12
|
$3.80 | $3.50 | -100.00% | 2 | $275.77M |
| NEWT | NewtekOne | Hold |
16
|
$11.16 | $15.63 | 16.49% | 2 | $269.33M |
| MFIN | Medallion Financial | Outperform |
11
|
$7.85 | $11.00 | 52.87% | 0 | $209.87M |
| OXSQ | Oxford Square Capital | Hold |
13
|
$3.23 | $4.75 | -40.25% | 0 | $181.36M |
| PTMN | Portman Ridge Finance | Outperform |
13
|
$19.74 | $21.50 | 1.32% | 2 | $179.12M |
| MRCC | Monroe Capital | Hold |
14
|
$7.42 | $8.67 | 21.29% | 5 | $163.58M |
| OFS | OFS Capital | Hold |
16
|
$9.52 | $10.75 | 5.04% | 2 | $126.33M |
| PFX | PhenixFIN | Hold |
8
|
$44.88 | $35.00 | -100.00% | 0 | $89.37M |
| LRFC | Logan Ridge Finance | Buy |
10
|
$22.30 | $27.00 | 12.11% | 1 | $59.32M |
| TURN | 180 Degree Capital | - |
-3
|
$4.06 | $12.00 | -100.00% | 0 | $38.50M |